Showing 1 - 5 results of 5 for search 'Seyed Reza Mousavi (13223324)', 查询时间: 0.01s Refine Results
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. 由 Seyed Reza Mousavi (13223324)

    出版 2025
    加到收藏夹
    Saved in:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. 由 Seyed Reza Mousavi (13223324)

    出版 2025
    加到收藏夹
    Saved in:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. 由 Seyed Reza Mousavi (13223324)

    出版 2025
    加到收藏夹
    Saved in:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. 由 Seyed Reza Mousavi (13223324)

    出版 2025
    加到收藏夹
    Saved in:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. 由 Seyed Reza Mousavi (13223324)

    出版 2025
    加到收藏夹
    Saved in:

检索工具: